Read More Earnings Equities General Guidance Markets News Dana Q1 Earnings Smashes Estimates; FY23 Targets Remain Unchanged By Shivani Kumaresan April 28, 12:16 PM Dana Inc (NYSE:DAN) reported first-quarter FY23 sales growth of 7% year-on-year to $2.64 billion, beating the consensus of $2.56 billion. The… DAN
Read More Biotech General Health Care Large Cap Legal News First U.S. Trial Over Zantac’s Alleged Cancer-Causing Properties Set For November In California By Vandana Singh July 3, 8:50 AM The initial U.S. court trial concerning the antacid medication Zantac is slated to commence on November 13 in a state court in California, as stated by a lawyer representing the plaintiffs. GSK
Read More Earnings Equities Guidance Markets News Small Cap GDS Holdings Tops Q2 Estimates, Reaffirms FY23 Outlook By Lekha Gupta August 22, 9:29 AM GDS Holdings Ltd (NASDAQ: GDS) reported a Q2 FY23 net revenue growth of 7.0% Y/Y to $340.91 million, beating the GDS
Read More Analyst Ratings News Price Target Baird Maintains Neutral on Heartland Express, Raises Price Target to $17 By Benzinga Newsdesk August 23, 7:44 AM Baird analyst Garrett Holland maintains Heartland Express (NASDAQ:HTLD) with a Neutral and raises the price target from $14 to $17. HTLD